$GANX 8-K SEC Filings

Filed On	Filing
01 Oct 2026	8-K: Other Events On October 1, 2026, Gain Therapeutics, Inc. (the “Company”) issued a press release announcing the presentation of a poster at the International Congress of Parkinson’s Disease and Movement Disorders, being held October 4-8, 2026, in Seou...
28 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers On September 22, 2026, Gianluca Fuggetta, Senior Vice President of Finance, principal financial officer, and principal accounting officer of Gain Therapeutics, Inc. (the “Company”), notified the Company of his intention to resign from hi...
11 Aug 2026	8-K: Results of Operations and Financial Condition
16 Jul 2026	8-K: Other Events
29 Jun 2026	8-K: Other Events
25 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
26 May 2026	8-K: Other Events
11 May 2026	8-K: Results of Operations and Financial Condition
26 Mar 2026	8-K: Results of Operations and Financial Condition
18 Mar 2026	8-K: Regulation FD Disclosure; Other Events
03 Feb 2026	8-K: Regulation FD Disclosure
18 Dec 2025	8-K: Other Events
28 Nov 2025	8-K: Other Events
12 Nov 2025	8-K: Results of Operations and Financial Condition
14 Oct 2025	8-K: Regulation FD Disclosure
09 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation
06 Oct 2025	8-K: Other Events
12 Aug 2025	8-K: Results of Operations and Financial Condition
17 Jul 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
30 Jun 2025	8-K: Other Events

Comments